Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Accenture
Johnson and Johnson
AstraZeneca
Merck
Daiichi Sankyo
Medtronic
Dow
Cantor Fitzgerald
QuintilesIMS

Generated: February 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019693

« Back to Dashboard

NDA 019693 describes DECABID, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the DECABID profile page.

The generic ingredient in DECABID is indecainide hydrochloride. Additional details are available on the indecainide hydrochloride profile page.
Summary for 019693
Tradename:DECABID
Applicant:Lilly
Ingredient:indecainide hydrochloride
Patents:0

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 50MG BASE
Approval Date:Dec 29, 1989TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 75MG BASE
Approval Date:Dec 29, 1989TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrengthEQ 100MG BASE
Approval Date:Dec 29, 1989TE:RLD:No

Expired US Patents for NDA 019693

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-003 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-003 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-003 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-002 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Lilly DECABID indecainide hydrochloride TABLET, EXTENDED RELEASE;ORAL 019693-001 Dec 29, 1989 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Merck
McKinsey
Boehringer Ingelheim
Citi
Deloitte
Argus Health
Fuji
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot